Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Genome & Company receives FDA IND clearance for GEN-001, its first anti-cancer microbiome therapeutic 2020-04-20 14:41
Korean Technology Start-Up Company UFIRST Co., Ltd Launches a Smart Hearing Aid 2020-04-20 01:00
GC Pharma lights up to celebrate 'World Hemophilia Day' 2020-04-17 21:00
Bluevisor chosen for NatWest FinTech Accelerator Programme 2020-04-17 20:30
Pearl Abyss Begins Final Beta for Shadow Arena 2020-04-17 13:16
Fondazione Internazionale Menarini Creates a New Covid-19 "Virtual" Library for Doctors and Nurses: It Takes Only a Click to get the Studies Chosen by Nobel Ignarro 2020-04-17 03:32
GSIL and Samsung Engineering Sign Contract for Smart Safety Management System 2020-04-16 20:30
IVI, INOVIO, and KNIH to Partner with CEPI in Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine in South Korea 2020-04-16 18:00
Ancient Ruins Season 2 And Other Updates Arrive in Black Desert Mobile 2020-04-15 10:00
Ancient Ruins Season 2 And Other Updates Arrive in Black Desert Mobile 2020-04-15 10:00
SKEMA Business School's EQUIS Accreditation Renewed for Another Five Years 2020-04-15 09:07
Medit Receives ISO/IEC 27001 Certification for Information Security Management 2020-04-14 15:01
VUNO Med(R)-Fundus AI(TM) receives MFDS Regulatory Approval as Class III Medical Device 2020-04-14 07:36
Smart speaker broadcasts made easy through Wecast.ai 2020-04-14 00:00
AITRICS and Cleveland Clinic collaborate to verify AI-based sepsis prediction solution 2020-04-14 00:00
Seegene Receives Health Canada Approval for its COVID-19 Assay 2020-04-13 21:00
VisualCamp launches 'SeeSo' website, mobile eye tracking SDK 2020-04-13 20:30
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture of SARS-COV-2 Antibodies for Potential COVID-19 Treatment 2020-04-10 11:39
CQC and Total Announce Multi-year Collaboration to Develop Quantum Algorithms for Carbon Capture, Utilization and Storage (CCUS) 2020-04-09 22:45
Bridge Biotherapeutics Discloses Interim Results from the First Cohort of Phase 2a Study of BBT-401, an Experimental Drug for Ulcerative Colitis 2020-04-09 15:14
1 280 281 282 283 284 412